Fat degrading enzyme implicated in type 2 diabetes

Karolinska Institutet
Investigators at Karolinska Institutet have identified a potential therapeutic target for treatment of obesity-associated metabolic diseases such as type 2 diabetes and nonalcoholic hepatic steatosis. The work, performed in collaboration with scientists at the University of California, Berkeley and Danderyd Hospital, is published in Cell Reports. The researchers utilized advanced biochemical techniques to map activities of an enzyme family in liv